See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: June 21, 2007

COPD (Chronic Obstructive Pulmonary Disease) Irritable Bowel Syndrome (IBS) Diabetes Mellitus Types I and II

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

COPD (Chronic Obstructive Pulmonary Disease)

People at least age 40, in general good health, and who have symptoms of chronic obstructive pulmonary disease (shortness of breath and/or productive cough) may qualify for this trial of an investigational medication. The study may last up to 26 weeks.

The research site is in Wheat Ridge, Colo.

More information

Please see http://www.centerwatch.com/patient/studies/cat44.html.

-----

Irritable Bowel Syndrome (IBS)

This study of an investigational medication will evaluate whether it helps relieve symptoms of irritable bowel syndrome. Participants will receive all study related exams and investigational medication at no cost, and may be compensated up to $650 for time and travel.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat90.html.

-----

Diabetes Mellitus Types I and II

You may qualify to participate in this trial and receive an "at home" diabetes test kit. Participants will review test results with a qualified medical professional. Candidates 45 or older may be included who are overweight or inactive, have a family history of diabetes, or are African American, Native American, Hispanic, or Asian.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat55.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.